isothermal amplification Diagnostics News

May 26, 2020

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

Premium

The company's adaptive low-resource testing technology requires no instrumentation and limited equipment, making it adaptable to settings without clinical lab infrastructure.

May 21, 2020

Head-to-Head Comparisons of Commercial SARS-CoV-2 MDx Tests Point to Few Differences in Accuracy

Premium

More than a dozen studies have been published to date directly comparing molecular diagnostic COVID-19 tests, with some detecting differences, mostly in sensitivity.

May 15, 2020

Becton Dickinson to Expand Into Point-of-Care MDx With NAT Diagnostics Acquisition

Premium

The acquisition will round out BD's molecular portfolio and be complementary to the firm's Veritor immunoassay system, according to executives.

Apr 20, 2020

Tangen Biosciences Wins $696K BARDA Contract to Develop Point-of-Care Coronavirus MDx Test

The test is expected to run on Tangen's GeneSpark nucleic acid amplification platform and achieve a CLIA waiver for use in doctors' offices.

Apr 16, 2020

Atila Isothermal qPCR Coronavirus Test Proves Easy to Use, Sensitive in Preliminary Evaluations

The Atila iAMP test was granted Emergency Use Authorization earlier this week and is being evaluated in multiple US labs.

Apr 13, 2020

Instrument-Free POC Molecular Coronavirus Test Being Developed by Sense Biodetection

The UK-based firm anticipates that it will have a high sensitivity test available in a few months that can detect active infections.

Apr 01, 2020

Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

Bringing testing closer to patients could be helpful, provided enough tests and instruments can be manufactured and distributed.

Mar 27, 2020

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

The ID Now COVID-19 test is the second assay from the company to receive EUA from the FDA, following the same designation issued to the Abbott RealTime SARS CoV-2.

Mar 23, 2020

Heat Biologics, U of Miami Partner to Develop Rapid Point-of-Care Coronavirus Test

The molecular assay is expected to require a pharyngeal throat swab to deliver diagnostic results on a paper strip in under 30 minutes.

Jan 30, 2020

Atila Biosystems High-Throughput Isothermal HPV Test Validated in Study

Premium

The system showed good performance for cervical samples as well as orophyrengeal samples, and required no extraction step.

Menu

isothermal amplification

With Low-Cost SARS-CoV-2 Assay, FYR Diagnostics Looks to Bypass Equipment Bottlenecks

Head-to-Head Comparisons of Commercial SARS-CoV-2 MDx Tests Point to Few Differences in Accuracy

Becton Dickinson to Expand Into Point-of-Care MDx With NAT Diagnostics Acquisition

Tangen Biosciences Wins $696K BARDA Contract to Develop Point-of-Care Coronavirus MDx Test

Atila Isothermal qPCR Coronavirus Test Proves Easy to Use, Sensitive in Preliminary Evaluations

Instrument-Free POC Molecular Coronavirus Test Being Developed by Sense Biodetection

Despite Potential, Experts Debate Whether Decentralized MDx for Coronavirus Can Flatten Curve

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

Heat Biologics, U of Miami Partner to Develop Rapid Point-of-Care Coronavirus Test

Atila Biosystems High-Throughput Isothermal HPV Test Validated in Study

Pages

Breaking News

Guardant Health Prices $315M Public Offering

Sienna Cancer Diagnostics, Triolab Ink Distribution Deal for Bladder Cancer Test in Sweden

Ravgen Sues Natera Over Cell-Free DNA Genetic Testing Patents

Agilent to Raise $500M Through Senior Notes Offering

Coca-Cola Bottle Maker, Longhorn Diagnostics Partner on Coronavirus Test Tube Manufacture

MeMed Receives CE-IVD Mark for Infectious Disease Test, POC Platform